Skip to main content
. 2016 Nov 8;6:36378. doi: 10.1038/srep36378

Figure 2. Circulating CD3CD19+ B cells were significantly increased in JORRP patients.

Figure 2

(a) The percentage of CD3CD19+ B cells in peripheral blood from JORRP patients (n = 34) and health control (n = 40) were analyzed by flow cytometry. (b,c) Phenotype analysis of CD3CD19+ B cells. Data were expressed as the mean ± SEM. Each dot represents one individual. *P < 0.5, **P < 0.01, ns = not significantly different.